Unitaid commits US$28.6 million to integrate diagnostic services across Africa and Asia

By Unitaid • Nov 19, 2026

Unitaid is investing US$28.6 million to expand access to testing for multiple diseases through two complementary projects led by the Aurum Institute and Benin’s National Tuberculosis Program, according to a press release issued on 17 November 2026. The initiative will span countries across Africa and Asia, focusing on tuberculosis (TB), HIV, human papillomavirus (HPV) and other sexually transmitted infections (STIs). It will also explore how diagnostic platforms for these diseases can expand access to testing for other conditions. The projects aim to connect diagnostic services and identify conditions that might otherwise go undetected. The investment seeks to help more people access the tests and care they need.

Health services, including testing, are often organized around single diseases, requiring patients to make repeated visits, wait longer for a diagnosis or miss necessary tests. The Lancet Commission on Diagnostics estimates that nearly half of the world’s population has little or no access to essential diagnostic services. Delays in testing can postpone treatment and contribute to the spread of disease. The new investment will examine the full pathway from testing and diagnosis to referral and treatment. It will also generate evidence on when and where integrated approaches can benefit patients and health systems.

The Multi-disease Integrated Diagnostics Access & Scale-up (MIDAS) project, led by the Aurum Institute, is a four-year initiative supporting governments in India, Kenya, Mozambique, Viet Nam and Zambia. It will help identify priority gaps in diagnostic services and develop approaches tailored to national priorities and health-system realities. South Africa and Cameroon will engage through more focused activities. MIDAS will assess benefits, costs and operational requirements to inform national decisions on sustainable expansion. The project will also evaluate how routine facility and community visits can create more opportunities to diagnose undetected conditions.

In parallel, Benin’s National Tuberculosis Program will lead Pooled Optimization & Integrated Testing (POOL-IT) across Bangladesh, Benin, Cameroon, Nigeria and Rwanda. The project explores how pooled testing can expand access to molecular diagnostics and reduce costs for diseases including HIV, TB, hepatitis B and C, HPV and STIs. “Innovation is not always about developing new technologies. Sometimes, it is about finding better ways to use what we already have,” said Prof. Dissou Affolabi, Director of Benin’s National Tuberculosis Programme. Unitaid-supported research previously informed the World Health Organization recommendation on pooled testing in resource-constrained settings earlier this year.

Together, MIDAS and POOL-IT will provide evidence, practical tools and implementation experience for countries. They will help determine where integrated diagnostics and pooled testing can add value and how to finance and sustain them. Janet Ginnard, Director of Strategy at Unitaid, noted that expanding access to diagnostics is about making smarter use of existing health systems. The findings are expected to inform wider adoption beyond the participating countries. The projects will work with country, regional and global partners throughout implementation.

Share